|
Written by administrator
|
|
среда, 28 января 2009 |
Двадцать третьего января американская компания Geron сообщила, что ею было получено разрешение на проведение первой фазы ограниченных клинических испытаний для пациентов с травмами спинного мозга. У компании за плечами большой опыт доклинических испытаний применения ЭСК в экспериментах на животных.В клинических испытаниях примут участие от восьми до десяти пациентов. В зону повреждения спинного мозга им будут инъецированы олигодендроциты (вспомогательные клетки в центральной нервной системе), полученные из эмбриональных стволовых клеток. Исследователи надеются, что трансплантированные олигодендроциты образуют вокруг поврежденных нейронов миелиновые оболочки, необходимые для проведения нервных импульсов, а также окажут стимулирующее воздействие на регенерацию нервных клеток. По крайней мере, на животных были показаны именно такие эффекты [1].Испытания планируется начать в семи американских медицинских центрах в начале лета 2009 года. Президент компании Geron Томас Окарма (Thomas Okarma) заявил, что начало этих испытаний «знаменует рассвет новой эры в терапии. Этот подход позволит в будущем отказаться от таблеток и скальпелей и достичь нового уровня в лечении».
|
|
|
Written by administrator
|
|
среда, 28 января 2009 |
|
Study Refutes Claims on AIDS Drug Trials New York Times - United States Mr. Mattingly said the agency had already taken steps to ensure that policies are properly enforced in any future clinical trials involving foster children. ... See all stories on this topic A randomised controlled trial of the Neuro Emotional Technique ... 7thSpace Interactive (press release) - New York,NY,USA Design/methodsA placebo controlled, double blind randomised clinical trial was designed to assess the effectiveness of NET on a cohort of children with ... See all stories on this topic FDA's green light for stem cell trial thrills scientists FierceBioResearcher - Washington,DC,USA The FDA's decision to allow Geron to launch the first clinical trial of an embryonic stem cell therapy has sent a jolt of optimism--along with an ... See all stories on this topic
|
|
|
Written by administrator
|
|
пятница, 12 декабря 2008 |
|
SARcode Announces Completion of Phase 1 Clinical Trial of SAR 1118 ... MarketWatch - USA SAN FRANCISCO, Dec 11, 2008 (BUSINESS WIRE) -- SARcode Corporation, a privately-held biopharmaceutical company focused on developing small molecule LFA-1 ... See all stories on this topic Clinical Trial: No Cardiosource - Washington,DC,USA Future clinical studies with CETP inhibitors that don’t raise blood pressure and/or lack the aldosterone-like effect on Na and K may resolve this critical ... See all stories on this topic Lilly Highlights Transformation Strategy for Wall Street, Reviews ... MarketWatch - USA Enzastaurin - A Phase III clinical trial is currently under way for the use of enzastaurin as a maintenance therapy for diffuse large B-cell lymphoma. ... See all stories on this topic
|
|
|
Written by administrator
|
|
среда, 26 ноября 2008 |
|
Cookeville Regional Now Affiliated With Clinical Trials Group UC Daily News - Upper Cumberland,TN,USA SWOG is one of the largest cancer clinical trials cooperative groups in the United States. Funded by research grants from the National Cancer Institute ... See all stories on this topic Pediatric Research Gets Boost From Web Journal of American Medical Association (subscription) - Chicago,IL,USA For parents already stressed from caring for a child with an illness, deciding whether to enroll their youngster in a relevant clinical trial can be a ... See all stories on this topic Researchers Increasingly Conduct 'Real World' Clinical Trials To ... Kaiser network.org - Washington,DC,USA ... series called "The Evidence Gap," examined the "growing movement" among researchers to conduct "pragmatic," or "real world," clinical trials to gather ... See all stories on this topic
|
|
|
Written by administrator
|
|
вторник, 25 ноября 2008 |
|
Labopharm to host webcast presentation on novel trazodone ... MarketWatch - USA ... the clinical data from Labopharm's positive Phase III clinical trial for its novel trazodone formulation, including a presentation of additional data. ... See all stories on this topic Schering-Plough Reports Preladenant Meets Primary Endpoint in ... MarketWatch - USA The dose-finding study was a randomized, placebo-controlled, double-blind, multicenter, multinational clinical trial that evaluated the efficacy and safety ... See all stories on this topic Biovail Announces US Availability of Xenazine(R) Tablets MarketWatch - USA The most frequent adverse events reported with Xenazine(R) compared to placebo in a randomized, 12-week, placebo controlled clinical trial of HD subjects ... See all stories on this topic
|
|
|
Written by administrator
|
|
вторник, 18 ноября 2008 |
|
Clinical trials needed to speed cancer fight Boston Globe - United States I am sure as a participant in a clinical trial, she signed an informed consent and acknowledged beforehand that severe complications, including death, ... See all stories on this topic Provectus Pharmaceuticals Adds Sixth Center to Phase 2 Clinical ... Business Wire (press release) - San Francisco,CA,USA ... Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the ... See all stories on this topic Clinical Trial Participants Miss Out On the Accolades Diabetes Health (press release) - Fairfax,CA,USA Only 9 percent believe that clinical trial volunteers make the greatest contribution to mankind. Oddly, ninety-four percent of the public recognizes that ... See all stories on this topic
|
|
|